Over the last decade significant advances have been made in the performance of nephrology-related procedures. Today, many nephrologists are routinely performing renal ultrasonography, ultrasound-guided renal biopsy, tunneled hemodialysis catheter insertion and percutaneous endovascular interventions. Recent data have demonstrated that the performance of nephrologyrelated procedures by an interventional nephrologist can provide effective, efficient and prompt care to the patient with renal disease and that these procedures can be safely and successfully performed by a nephrologist trained in interventional nephrology (IN) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) .
The "renal ultrasonography by the nephrologist" concept was first introduced by Charles O'Neill in the United States in the 1990's (3). Ultrasound is a safe and simple tool that can be employed effectively by nephrologists as a critical element in the diagnostic workup of a patient with renal disease. Since interpretation of these studies relies a great deal on clinical correlation, nephrologists are ideally suited to perform renal sonography (3, 8, 11) . When performed by the nephrologist, ultrasonography yields prompt diagnostic information that can be incorporated into a differential diagnosis and allow treatment plans to be quickly formulated. Both diagnostic sonography and ultrasound-guided renal biopsy can be safely performed at the bedside, thus avoiding scheduling, transportation and radiology suite time restrictions (1, 5) . In contrast, ultrasounds obtained through radiology are often subject to delays which are inherent in system and are usually performed by a technician which further requires interpretation by the radiologist. Moreover, most renal biopsies are performed in a radiology suite, increasing the cost and introducing the possibility of further delays. By performing renal biopsy at the bedside a nephrologist can minimize delays and provide care in a timely manner. Indeed, data from our center (a busy academic teaching hospital) showed that the time required to obtain a renal ultrasound on an outpatient basis was markedly reduced from 46.5 ± 2.4 days (mean ± SE) using radiology to 4.7 ± 0.7 days (mean ± SE) when performed by the IN service (5).
Emory was the first university to offer a comprehensive ultrasonography course exclusively for nephrologists. In addition, the first "Atlas of Renal Ultrasonography" was published in an effort to familiarize nephrologists with renal sonography (16) . The most common indications for renal ultrasound include acute and chronic renal failure, hematuria, severe hypertension, neoplasms, nephrolithiasis, infections, renal allograft dysfunction, anatomical urinary tract abnormalities and ultrasound guidance for percutaneous renal biopsy (8, 11, 15) . Through comprehensive training focused on renal ultrasonography (17) and application of clinical and laboratory data, a nephrologist can utilize this tool to its maximum potential in the evaluation of renal disease.
Recent data have emphasized that many nephrologists are routinely performing peritoneoscopic insertion of peritoneal dialysis catheter routinely (4, 7, 9, 10, 12, 17) . This technique offers the advantage of direct visualization of intraperitoneal structures (bowel loops, omentum, adhesions), allows for quick diagnosis of intraperitoneal bleeding and determines the most suitable site for catheter placement (4, 7, 9, 10, 12,) . This approach minimizes chances of visceral injury and placement of the catheter in an undesired location (upper quadrants, omentum). A few important issues should be highlighted in terms of PD catheter placement by the nephrologist. First, the procedure can be safely performed in a procedure room, interventional lab or an intensive care unit using standard precautions for infection control (4, 7, 10) . Since tissue dissection is minimal with this technique, the postoperative course is brief and the catheter can be used immediately for dialysis (4, 12) , although a two-week postoperative period for wound healing is recommended (3).
Conversely, the open surgical technique requires a surgeon, operating room facilities and staff and general anesthesia. The latter approach introduces delays and restrictions inherent in the system and increases costs. At our center, the average time between the initial contact with the IN team and PD catheter insertion was markedly shortened to 6.4 ± 0.9 days (mean ± SE) in contrast to our prior experience with catheters placed by the surgeons 34.3 ± 1.6 days (mean ± SE) (5). Furthermore, by utilizing local anesthesia the risks of general anesthesia can be avoided altogether. Mortality risk from general anesthesia varies with the American Society of Anesthesia (ASA) physical status categories (18, 19) . Class I includes patients with no physiologic or psychologic stress (minimal risk) and class V describes patients with severe systemic disturbances (18, 20) . Many investigators have documented that mortality risk rises as the ASA physical status class deteriorates (20) (21) (22) (23) . For class II patients (mild to moderate systemic disturbances such as essential hypertension, diabetes or anemia) mortality is estimated to be 0.03%, increasing to 1.8% for class III and 7.8% for class IV patients (20) (21) (22) (23) . End stage renal disease patients usually have multiple complex and advanced medical problems, thus avoiding general anesthesia and its inherent risks is a major advantage.
Peritoneoscopic placement of PD catheters has been rigorously compared with the surgical technique (10, 24, 25) . A recent randomized trial comparing peritoneoscopic (P) versus surgical (S) technique clearly demonstrated prolonged catheter survival with peritoneoscopic placement (P=77.5% vs. S=62.5% (p=0.02) at 12 months; P=63% vs. S=41.5% (p=0.01) at 24 months; P= 51.3 vs. S=36% (p=0.04) at 36 months) (10) . In addition, overall catheter failure rates were higher in the surgical as compared to the peritoneoscopic group (S=55.2% vs. P=32.8%; p=0.003). In addition, there was a higher incidence of early peritonitis (S=12.5% VS. P=2.6%; p=0.02) and leak (S=11.1 VS. P=1.3%; p=0.002) in the surgical cohort. There was no difference in terms of visceral injury between the two procedure groups. Other investigators have also shown fewer catheter-related complications and longer catheter survival with peritoneoscopic technique when compared with surgical placement (12, (24) (25) .
At the University of Miami we found a positive impact on the growth of our PD population when nephrologists began performing PD access placement surgery. Other investigators have reported similar results (26) . Recent data has shown that virtually all catastrophic dialysis start patients (patients who present with ESRD having never been seen before by a nephrologist) are initiated on HD and few, if any, are ever offered a choice of dialysis modality (27) . With the development of our PD access placement program, we were able to present a choice of dialysis modality to these patients. In addition, we were able to successfully begin PD by placing a permanent PD access immediately, thereby avoiding the need for a tunneled hemodialysis catheter (4). In contrast, prior to the development of our PD access program, PD catheter insertion during the initial admission was not available nor was early initiation of acute PD a reasonable option.
Adequate hemodialysis of ESRD patients depends upon a reliable vascular access (28) . This is commonly achieved by a tunneled cuffed dialysis catheter, arteriovenous fistula (AVF) or an arteriovenous graft (AVG) (14, (31) (32) (33) (34) (35) (36) (37) (38) (39) . Percutaneous tunneled dialysis catheters are frequently used as a bridge to the placement of a permanent vascular access (AVF, AVG) (14, 28, 29) . However, inherent delays in the placement of a tunneled catheter and the surgical creation of a permanent access in the ESRD patient frequently requires the placement of a temporary dialysis catheter, with its inherently greater risk of infection (28) (29) (30) (31) . In addition, the busy schedule of interventional radiologists forces them to delay tunneled dialysis catheter placement or vascular access declotting until late in the day, at which point these procedures are often cancelled and rescheduled secondary to other emergency procedures. This generates the need for temporary dialysis catheter placement thus increasing both the risk of infection and cost. An interventional nephrologist can promptly insert a tunneled dialysis catheter and declot a clotted access as necessary in order to avoid the placement of a temporary dialysis catheter and minimize missed dialysis treatments (13, 14, (30) (31) (32) (33) .
Identification of a poorly functioning vascular access and correction of stenoses results in prolonged survival of the access, increased blood flow and a decrease in access thrombosis, access replacement, hospitalization related to vascular access, access-related missed dialysis days and decreased cost for thrombosis-related events (6, 13, (28) (29) (30) (31) (32) (33) (34) (35) (36) . A nephrologist can effectively establish a surveillance program to monitor vascular access function and identify the failing access. Stenosis and thrombosis are major causes of access failure in arteriovenous fistulae and grafts (6, 28, 31, 34, 35) . A nephrologist trained in this aspect of IN can perform percutaneous balloon angioplasty to correct vascular stenosis (35) . Recently, Beathard et al (37) provided invaluable information regarding how to improve the function of an AVF that is not developing properly. In their prospective observational series, 63 patients who failed to develop their fistulae sufficiently to sustain dialysis were evaluated by physical examination and angiography. Venous stenosis and accessory veins (venous side branches) were common findings. Following treatment by percutaneous balloon angioplasty, accessory vein ligation or a combination of both, these investigators salvaged 52 (82.5%) of the 63 failing fistulae. Other nephrologists have described a percutaneous technique for accessory vein ligation of arteriovenous fistulae that failed to achieve adequate blood flow for hemodialysis or size for successful cannulation (38) .
Procedures such as tunneled cuffed dialysis catheter, percutaneous balloon angioplasty for vascular access stenosis, declotting of a clotted vascular access and salvage of a failed AVF are being performed successfully by nephrologists on an outpatient basis (6, 13, 14, 32, 33, 35, 37, 38) . This approach ensures prompt delivery of this much-needed aspect of ESRD and should improve patient outcomes.
The prevalence of arteriovenous fistulae in the U.S. remains disappointingly low (~27%) (39) . Little attention is paid to AVF creation by U.S. nephrologists despite the widespread evidence that a higher incidence of complications (stenosis, thrombosis, access failure, infection) and increased mortality and cost are associated with arteriovenous grafts and tunneled hemodialysis catheters (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) . Of interest, the arteriovenous fistula for hemodialysis was first introduced by nephrologists (50); however, U.S. nephrologists gradually abandoned this procedure. In contrast, many European nephrologists are actively engaged in creating arteriovenous fistulae and have reported excellent outcomes (51) (52) (53) (54) (55) (56) (57) . United States nephrologists should approach the issue of vascular access creation in the same manner as other nephrologyrelated procedures. Nephrologists should consider gaining the necessary experience and the required training to enable them to join forces with surgeons to provide this aspect of care to hemodialysis patients.
In conclusion, the performance of nephrology-related procedures by interventional nephrologists is a significant advance in the effort to provide optimal care to a growing number of patients with renal disease. Nephrologists with proper training in IN can perform these procedures safely and effectively. An increasing number of practicing nephrologists and nephrology trainees are developing a keen interest in procedural nephrology. However, at present there are insufficient numbers of trained invasive nephrologists and too few centers capable of providing the necessary training. The American Society of Diagnostic and Interventional Nephrology (ASDIN) is making rapid advances to establish training centers in this growing area of nephrology. Directors of Nephrology training programs will need to take a leadership role in the development of Interventional Nephrology within the structure of our current curriculum. This may require allowing existing faculty to train at another center to bring this knowledge back to the program or having fellows obtain additional training in this area apart from the traditional nephrology core curriculum.
A. ASIF
Director, Interventional Nephrology, Assistant Professor of Medicine, University of Miami School of Medicine, Miami, FL, USA
